Biosensors: Nomura maintains Buy with TP $1.59. Note that BiomatrixFlex receives reimbursement approval in France. Approval for reimbursement in France for BioMatrix Flex™ should strengthen Biosensors market position in the DES market in Europe. Add that Biosensors is now well positioned for its next stage of growth with China and Japan will be key drivers of revenue growth….
Add that with a stronger balance sheet, see Biosensors embarking on M&A to further consolidate its position while venturing into product adjacencies.
No comments:
Post a Comment